Saturday 28 February 2009

Dolorac




In the US, Dolorac (capsaicin topical) is a member of the drug class miscellaneous topical agents and is used to treat Diabetic Nerve Damage, Osteoarthritis and Persisting Pain - Shingles.

US matches:

  • Dolorac

Ingredient matches for Dolorac



Ibuprofen

Ibuprofen lysine (a derivative of Ibuprofen) is reported as an ingredient of Dolorac in the following countries:


  • Spain

International Drug Name Search

Friday 27 February 2009

Oxybutynine HCl Ratiopharm




Oxybutynine HCl Ratiopharm may be available in the countries listed below.


Ingredient matches for Oxybutynine HCl Ratiopharm



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynine HCl Ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

Norepinephrine




In the US, Norepinephrine (norepinephrine systemic) is a member of the following drug classes: catecholamines, vasopressors and is used to treat Hypotension and Shock.

US matches:

  • Norepinephrine

  • Norepinephrine Bitartrate

  • Norepinephrine (Levarterenol)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01CA03

CAS registry number (Chemical Abstracts Service)

0000051-41-2

Chemical Formula

C8-H11-N-O3

Molecular Weight

169

Therapeutic Category

α-Sympathomimetic agent

Chemical Name

1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-

Foreign Names

  • Norepinephrinum (Latin)
  • Norepinephrin (German)
  • Norépinéphrine (French)
  • Norepinefrina (Spanish)

Generic Names

  • Noradrenalina (OS)
  • Noradrenaline (OS: BAN)
  • Noradrénaline (OS: DCF)
  • Norepinephrine (OS: BAN)
  • Levarterenol (IS)
  • Noradrenalin (IS)
  • Noradrenalini solutio iniectabilis (PH: Ph. Helv. 8)
  • Norepinephrine (PH: JP XIV)
  • Noradrenaline Hydrochloride (OS: BANM)
  • Norepinephrine Hydrochloride (OS: BANM)
  • Noradrénaline (chlorhydrate de) (PH: Ph. Eur. 6)
  • Noradrenaline Hydrochloride (PH: BP 2010, Ph. Eur. 6)
  • Noradrenalini hydrochloridum (PH: Ph. Eur. 6)
  • Norepinephrine Hydrochloride (PH: BP 2010)
  • Noradrenaline Acid Tartrate (OS: BANM)
  • Norepinephrine Acid Tartrate (OS: BANM)
  • Norepinephrine Bitartrate (OS: USAN)
  • Noradrenaline Acid Tartrate (IS)
  • Noradrenalinium tartaricum (IS)
  • Norepinephrine Acid Tartrate (IS)
  • Noradrénaline (tartrate de) (PH: Ph. Eur. 6)
  • Noradrenaline Acid Tartrate (PH: BP 2010)
  • Noradrenaline Tartrate (PH: Ph. Eur. 6)
  • Noradrenalini tartras (PH: Ph. Eur. 6)
  • Norepinephrine Acid Tartrate (PH: BP 2010)
  • Norepinephrine Bitartrate (PH: USP 32)
  • Norepinephrinhydrogentartrat (PH: Ph. Eur. 6)

Brand Names

  • Levonor
    Ciech, Vietnam


  • Levophed
    Hospira, Peru


  • Lidocaina Cloridrato + Noradrenalina Salf (Norepinephrine and Lidocaine)
    Salf, Italy


  • Noradrenalin SAD
    Amgros, Denmark


  • Norepinefrina Northia
    Northia, Argentina


  • Norepinefrina
    Abbott, Peru


  • Rhinopront
    Mack, Luxembourg


  • Xylonor (Norepinephrine and Lidocaine hydrochloride)
    Septodont, Poland


  • Arterenol
    Sanofi-Aventis, Germany


  • Noradrenalin Leciva
    Leciva, Czech Republic


  • Adine
    Chile, Chile


  • Adrenor
    Samarth, India


  • Biodicaine Noradrenalinée (Norepinephrine and Lidocaine)
    Biodica, France


  • Fioritina
    Fada, Argentina


  • Levonor
    Polfa Warszawa, Poland


  • Levophed
    Abbott, Thailand; CTS, Israel; Hospira, Australia; Hospira, Canada; Hospira, Indonesia; Hospira, Ireland; Hospira, Luxembourg; Hospira, New Zealand; Hospira, Singapore; Hospira, Taiwan; Hospira, United States; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Egypt; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Jordan; Transfarma Medica Indah, Indonesia


  • Lidokain-noradrenalin SAD (Norepinephrine and Lidocaine)
    SAD, Denmark


  • Narcodon (Norepinephrine and Lidocaine)
    A.DH. Pharm, Greece


  • N-Epi
    Novell, Indonesia


  • Noradrenalin Abcur
    Abcur, Sweden


  • Noradrenalin Bichsel
    Bichsel, Switzerland


  • Noradrenalin Leciva
    Zentiva, Slovakia


  • Noradrenalina Biol
    Biol, Argentina


  • Noradrenalina Braun
    Braun, Spain


  • Noradrenalina Galenica
    Galenica Senese, Italy


  • Noradrenalina Monico
    Monico, Italy


  • Noradrenalina Richet
    Richet, Argentina


  • Noradrenalina Salf
    Salf, Italy


  • Noradrénaline (tartrate) Aguettant
    Aguettant, France; Aguettant, Malta; Aguettant, Tunisia


  • Noradrenaline Harvest Pharm
    Harvest Pharm, China


  • Noradrénaline Mylan
    Mylan, France


  • Noradrénaline Renaudin sans conservateur
    Renaudin, France


  • Noradrenaline Sintetica
    Sintetica, Switzerland


  • Noradrénaline tartrate Renaudin
    Renaudin, France


  • Noradrenaline
    Hospira, Malta


  • Norages
    Ges Genericos, Spain


  • Norepinefrina
    Bestpharma, Chile; Pharmakin, Venezuela


  • Norepinefrine CF
    Centrafarm, Netherlands


  • Norepinephrine Bitartrate
    Bedford, United States; Ben Venue, Israel; Metrics, United States; PharmaForce, United States; Sicor, United States; Teva USA, United States


  • Pridam
    Pisa, Mexico


  • Raivas
    Dexa Medica, Indonesia


  • Vascon
    Fahrenheit, Indonesia

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 22 February 2009

Orimune


Generic Name: poliovirus vaccine, live (Oral route)


POE-lee-oh VYE-rus VAX-een, lyve


Commonly used brand name(s)

In the U.S.


  • Orimune

Available Dosage Forms:


  • Solution

Therapeutic Class: Vaccine


Uses For Orimune


Poliovirus vaccine live oral (OPV) is an active immunizing agent used to prevent poliomyelitis (polio). It works by causing your body to produce its own protection (antibodies) against the virus that causes polio.


Polio is a very serious infection that can cause death. In survivors of poliovirus infection, polio causes paralysis of the muscles, including the muscles that enable you to walk and breathe. A polio infection may leave a person unable to breathe without the help of an iron lung, unable to walk without leg braces, or confined to a wheelchair. There is no cure for polio.


Immunization against polio is recommended for all infants from 6 to 12 weeks of age, all children, all teenagers up to 18 years of age, and certain adults who are at greater risk for exposure to polioviruses than the general population.


This vaccine is to be administered only by or under the supervision of your doctor or other healthcare professional.


Routine production of oral poliovirus vaccine (OPV) has been discontinued in the United States; an emergency stockpile is maintained in the event of a poliovirus outbreak.


Before Using Orimune


In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:


For a while after you are immunized, there is a very small risk that any persons living in your household who have not yet been immunized against polio or who have or had an immune deficiency condition may develop poliomyelitis (polio) from being around you. Talk to your doctor if you have any questions about this.


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


In the U.S. and Canada, use of OPV is not recommended for infants up to 6 weeks of age; however, the World Health Organization (WHO) recommends OPV vaccination at birth. For infants and children 6 weeks of age and older, OPV is not expected to cause different side effects or problems than it does in adults.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of OPV in the elderly with use in other age groups, this vaccine is not expected to cause different side effects or problems in older persons than it does in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this vaccine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Receiving this vaccine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Adalimumab

  • Azathioprine

  • Certolizumab Pegol

  • Etanercept

  • Everolimus

  • Fingolimod

  • Golimumab

  • Mycophenolic Acid

  • Rilonacept

  • Sirolimus

  • Tacrolimus

  • Temsirolimus

  • Ustekinumab

Receiving this vaccine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abatacept

  • Leflunomide

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Diarrhea or

  • Virus infection or

  • Vomiting—These conditions may reduce the useful effect of the vaccine.

  • Fever or

  • Illness, moderate or severe or

  • Weakness, severe—The symptoms of these conditions may be confused with possible side effects of the vaccine.

  • Immune deficiency condition, or family history of—The condition may increase the chance of side effects of the vaccine.

Proper Use of Orimune


Make sure your doctor knows if you are on any special diet, such as a low-sugar diet, because the OPV may be given to you on a sugar cube.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For prevention of polio:
    • For oral dosage form:
      • Adults and teenagers 18 years of age and older—One dose is given at your first visit, then a second dose is given 6 to 8 weeks later. A third dose is given 6 to 12 months after the second dose.

      • Infants and children up to 18 years of age—One dose is given at your first visit, then a second dose is given 6 to 8 weeks later. A third dose is given 8 to 12 months after the second dose. A booster dose is given at 4 to 6 years of age only if the third dose was given before the child's fourth birthday. The doses are taken by mouth.



Precautions While Using Orimune


Tell your doctor that you have received this vaccine or if you are to receive any other live virus vaccines within 1 month after receiving this vaccine.


Orimune Side Effects


In very rare instances, healthy persons who have taken the poliovirus vaccine live oral (OPV) and healthy persons who are close contacts of adults or children who have taken OPV have been infected by the polio virus and have become paralyzed.


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Symptoms of allergic reaction
  • Difficulty with breathing or swallowing

  • hives

  • itching, especially of the feet or hands

  • reddening of the skin, especially around ears

  • swelling of the eyes, face, or inside of the nose

  • unusual tiredness or weakness (sudden and severe)

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Orimune resources


  • Orimune Drug Interactions
  • Orimune Support Group
  • 0 Reviews · Be the first to review/rate this drug


  • Poliovirus Vaccine Inactivated Monograph (AHFS DI)


Saturday 21 February 2009

Bristacol




Bristacol may be available in the countries listed below.


Ingredient matches for Bristacol



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Bristacol in the following countries:


  • Spain

International Drug Name Search

Bupivacaine




In some countries, this medicine may only be approved for veterinary use.


In the US, Bupivacaine (bupivacaine systemic) is a member of the drug class local injectable anesthetics and is used to treat Cesarean Section and Local Anesthesia.

US matches:

  • Bupivacaine Solution

  • Bupivacaine in Dextrose Solution

  • Bupivacaine

  • Bupivacaine Hydrochloride

  • Bupivacaine Spinal

UK matches:

  • Bupivacaine & Adrenaline Injection BP 0.25% w/v, 1 in 200,000 (SPC)
  • Bupivacaine & Adrenaline Injection BP 0.5% w/v, 1 in 200,000 (SPC)
  • Bupivacaine Hydrochloride Infusion Solution BP 0.1% w/v (SPC)
  • Bupivacaine Hydrochloride Infusion Solution BP 0.125% w/v (SPC)
  • Bupivacaine Hydrochloride Injection BP 0.25% w/v, 10ml & 20ml (SPC)
  • Bupivacaine Hydrochloride Injection BP 0.375 % w/v (SPC)
  • Bupivacaine Hydrochloride Injection BP 0.5% w/v, 10ml & 20ml (SPC)
  • Bupivacaine Hydrochloride Injection BP 0.75% w/v (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N01BB01

CAS registry number (Chemical Abstracts Service)

0002180-92-9

Chemical Formula

C18-H28-N2-O

Molecular Weight

288

Therapeutic Category

Anesthetic, local

Chemical Name

2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-

Foreign Names

  • Bupivacainum (Latin)
  • Bupivacain (German)
  • Bupivacaïne (French)
  • Bupivacaina, Bupibacaina (Spanish)

Generic Names

  • Bupivacaina (OS: DCIT)
  • Bupivacaine (OS: BAN)
  • Bupivacaïne (OS: DCF)
  • Win 11318 (IS)
  • Bupivacaine Hydrochloride (OS: USAN, BANM)
  • AH 2250 (IS)
  • LAC-43 (IS)
  • Pyridinecarboxamide (IS)
  • Bupivacaïne (chlorhydrate de) (PH: Ph. Eur. 6)
  • Bupivacaine Hydrochloride (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Bupivacainhydrochlorid (PH: Ph. Eur. 6)
  • Bupivacaini hydrochloridum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Anestes
    Terbol, Peru


  • Bucaine
    Hikma, United Arab Emirates; Hikma, Egypt; Hikma, Iraq; Hikma, Jordan; Hikma, Kuwait; Hikma, Lebanon; Hikma, Libya; Hikma, Oman; Hikma, Qatar; Hikma, Saudi Arabia; Hikma, Sudan; Hikma, Syria; Hikma, Yemen


  • Bunascan
    Fahrenheit, Indonesia


  • Bupi
    Comiesa Druc, Peru


  • Bupicaine
    Unimed, Tunisia


  • Bupinest
    Trifarma, Peru


  • Bupinostrum
    Nostrum, Portugal


  • Bupivacainã
    Terapia, Romania


  • Bupivacaína
    Comiesa Druc, Peru; Dany, Peru; Sanderson, Peru


  • Bupivacaine
    Aguettant, Tunisia


  • Buvanest
    Kalbe, Indonesia


  • Marcaine Rachianesthesie
    AstraZeneca, Tunisia


  • Recain
    Mahakam Beta Farma, Indonesia


  • Abocain
    Unimed & Unihealth, Bangladesh


  • Bicain
    Orion, Finland


  • Bucain Actavis
    Actavis, Germany


  • Bucain
    Bernofarm, Indonesia; DeltaSelect, Austria; DeltaSelect, Germany; DeltaSelect, Hungary


  • Bucaine (veterinary use)
    Bomac, New Zealand


  • Bupafen (Bupivacaine and Fenatyl)
    Biomed, New Zealand


  • Bupibil
    Hospira, Italy


  • Bupicain + Adrenalina (Bupivacaine and Epinephrine)
    Monico, Italy


  • Bupicain
    Monico, Italy


  • Bupicaina
    Scott, Argentina


  • Bupiforan + Adrenalina (Bupivacaine and Epinephrine)
    Baxter-RM, Italy


  • Bupiforan
    Baxter-RM, Italy


  • Bupigobbi
    Gobbi, Argentina


  • Bupinex
    Richmond, Argentina


  • Bupirop
    Ropsohn, Peru


  • Bupisen + Adrenalina (Bupivacaine and Epinephrine)
    Galenica Senese, Italy


  • Bupisen
    Galenica, Italy


  • Bupisolver + Adrenalina (Bupivacaine and Epinephrine)
    Altaselect, Italy


  • Bupisolver
    Altaselect, Italy


  • Bupivacain ACS Dobfar Info
    ACS Dobfar Info, Switzerland


  • Bupivacain ActavisGroup
    Actavis Group, Netherlands


  • Bupivacain Jenapharm
    Mibe Jena, Germany


  • Bupivacain Jenapharm mit Epinephrin (Bupivacaine and Epinephrine)
    Mibe Jena, Germany


  • Bupivacain SAD
    Amgros, Denmark


  • Bupivacain Sintetica
    Sintetica, Switzerland


  • Bupivacaina Angelini
    Angelini, Italy


  • Bupivacaina Clorhidrato Hiperbarica
    Sanderson, Chile


  • Bupivacaina Clorhidrato
    Bestpharma, Chile; Biosano, Chile; Sanderson, Chile


  • Bupivacaina Fisiopharma
    Fisiopharma, Italy


  • Bupivacaina Gemepe
    Gemepe, Argentina


  • Bupivacaina Hiperbarica Braun
    Braun, Spain


  • Bupivacaina Hiperbarica
    Biosano, Chile


  • Bupivacaina Inyectable Braun
    Braun, Spain


  • Bupivacaina Recordati
    Recordati, Italy


  • Bupivacaina
    Abbott, Venezuela


  • Bupivacaine & Fentanyl (Bupivacaine and Fentanyl)
    Biomed, New Zealand


  • Bupivacaïne Aguettant Adrenaline (Bupivacaine and Epinephrine)
    Aguettant, France


  • Bupivacaïne Aguettant
    Aguettant, France


  • Bupivacaïne B. Braun
    Braun, France


  • Bupivacaine Bioren
    Sintetica-Bioren, Switzerland


  • Bupivacaine DeltaSelect
    DeltaSelect, Czech Republic


  • Bupivacaine Grindeks
    Grindeks, Latvia


  • Bupivacaine HCl PCH
    Pharmachemie, Netherlands


  • Bupivacaine HCl ratiopharm
    ratiopharm, Netherlands


  • Bupivacaine Hydrochloride and Epinephrine (Bupivacaine and Bupivacaine hydrochloride)
    Septodont, United States


  • Bupivacaine Hydrochloride and Epinephrine (Bupivacaine and Epinephrine tartrate)
    APP, United States; Hospira, United States; Septodont, United States


  • Bupivacaine Hydrochloride Baxter
    Baxter, Greece


  • Bupivacaine Hydrochloride
    DeltaSelect, Czech Republic; Hospira, United States; International Medication Systems, United States


  • Bupivacaine Injection
    PfizerPerth, Australia


  • Bupivacaïne Mylan
    Mylan, France


  • Bupivacaine
    Antigen, Oman; APP, United States


  • Bupivacain-Fentanyl Sintetica (Bupivacaine and Fentanyl)
    Sintetica, Switzerland


  • Bupivacain-Morfin SDA (Bupivacaine and Morphine)
    SAD, Denmark


  • Bupivacainum hydrochloricum
    Polfa Warszawa, Georgia; Polfa Warszawa, Lithuania; Polfa Warszawa, Poland


  • Bupixamol
    Molteni, Italy


  • Carbostesin
    AstraZeneca, Austria; AstraZeneca, Switzerland; AstraZeneca, Germany


  • Decain
    Dexa Medica, Indonesia


  • Dolanaest
    Gebro, Austria; Strathmann, Germany


  • Duracain
    Sintetica, Switzerland


  • Duracaína
    Behrens, Venezuela


  • Duracaine
    Techno, Bangladesh


  • Inibsacain Hiperbarica
    Inibsa, Spain


  • Inibsacain sin vasoconstr
    Inibsa, Spain


  • Kamacaine
    Kamada, Israel


  • Macaine
    Adcock Ingram Pharmaceuticals, South Africa


  • Marcain Dental (Bupivacaine and Epinephrine)
    Dentsply, Australia; Dentsply, New Zealand


  • Marcain Spinal
    AstraZeneca, Denmark; AstraZeneca, Hong Kong; AstraZeneca, Iceland; AstraZeneca, Sri Lanka; AstraZeneca, Lithuania; AstraZeneca, Norway


  • Marcain with Adrenalin (Bupivacaine and Epinephrine)
    AstraZeneca, Australia; AstraZeneca, Denmark; AstraZeneca, New Zealand


  • Marcain with Fentanyl (Bupivacaine and Fentanyl)
    AstraZeneca, Australia


  • Marcain
    AstraZeneca, United Arab Emirates; AstraZeneca, Australia; AstraZeneca, Bahrain; AstraZeneca, Denmark; AstraZeneca, Egypt; AstraZeneca, United Kingdom; AstraZeneca, Hong Kong; AstraZeneca, Hungary; AstraZeneca, Indonesia; AstraZeneca, Iraq; AstraZeneca, Iran; AstraZeneca, Iceland; AstraZeneca, Jordan; AstraZeneca, Japan; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Sri Lanka; AstraZeneca, Malta; AstraZeneca, Malaysia; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Qatar; AstraZeneca, Saudi Arabia; AstraZeneca, Sweden; AstraZeneca, Singapore; AstraZeneca, Syria; AstraZeneca, Thailand; AstraZeneca, Vietnam; AstraZeneca, Yemen; Sarabhai, India


  • Marcain (veterinary use)
    AstraZeneca, United Kingdom


  • Marcain adrenalin (Bupivacaine and Epinephrine)
    AstraZeneca, Sweden


  • Marcain spinal
    AstraZeneca, Sweden


  • Marcain spinal tung
    AstraZeneca, Denmark; AstraZeneca, Iceland; AstraZeneca, Norway; AstraZeneca, Sweden


  • Marcaina
    AstraZeneca, Brazil; AstraZeneca, Italy; AstraZeneca, Portugal


  • Marcain-Adrenalin (Bupivacaine and Epinephrine)
    AstraZeneca, Norway


  • Marcaine Spinal
    AstraZeneca, Czech Republic; AstraZeneca, Israel; AstraZeneca, New Zealand; AstraZeneca, Romania; AstraZeneca, Serbia; AstraZeneca, Thailand


  • Marcaine
    AstraZeneca, United Arab Emirates; AstraZeneca, Belgium; AstraZeneca, Bahrain; AstraZeneca, Cyprus; AstraZeneca, Czech Republic; AstraZeneca, Estonia; AstraZeneca, Egypt; AstraZeneca, Georgia; AstraZeneca, Ghana; AstraZeneca, Guyana; AstraZeneca, Israel; AstraZeneca, Iraq; AstraZeneca, Jordan; AstraZeneca, Kenya; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Luxembourg; AstraZeneca, Latvia; AstraZeneca, Libya; AstraZeneca, Malawi; AstraZeneca, Mozambique; AstraZeneca, Nigeria; AstraZeneca, Netherlands; AstraZeneca, Oman; AstraZeneca, Poland; AstraZeneca, Qatar; AstraZeneca, Romania; AstraZeneca, Serbia; AstraZeneca, Saudi Arabia; AstraZeneca, Sudan; AstraZeneca, Slovenia; AstraZeneca, Syria; AstraZeneca, Turkey; AstraZeneca, Taiwan; AstraZeneca, Tanzania; AstraZeneca, Uganda; AstraZeneca, Yemen; AstraZeneca, Zambia; AstraZeneca, Zimbabwe; Hospira, Canada; Hospira, United States


  • Neocaina
    Ethicalpharma, Peru


  • Regivell
    Novell, Indonesia


  • Sensorcaine
    APP, United States; AstraZeneca, Canada; AstraZeneca, India; AstraZeneca, Philippines; AstraZeneca, United States


  • Sensorcaine with Epinephrine (Bupivacaine and Epinephrine)
    APP, United States; AstraZeneca, Canada


  • Ultracaine
    Jayson, Bangladesh

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 20 February 2009

Adalat 2-Phasen




Adalat 2-Phasen may be available in the countries listed below.


Ingredient matches for Adalat 2-Phasen



Nifedipine

Nifedipine is reported as an ingredient of Adalat 2-Phasen in the following countries:


  • Austria

International Drug Name Search

Monday 9 February 2009

Chlortetracycline Uterine Boluses




Chlortetracycline Uterine Boluses may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Chlortetracycline Uterine Boluses



Chlortetracycline

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Chlortetracycline Uterine Boluses in the following countries:


  • Ireland

International Drug Name Search

Sunday 8 February 2009

Zanirisp




Zanirisp may be available in the countries listed below.


Ingredient matches for Zanirisp



Risperidone

Risperidone is reported as an ingredient of Zanirisp in the following countries:


  • Switzerland

International Drug Name Search

Bio-Cef


Generic Name: cephalexin (Oral route)

sef-a-LEX-in

Commonly used brand name(s)

In the U.S.


  • Bio-Cef

  • Keflex

  • Panixine DisperDose

In Canada


  • Novo-Lexin

Available Dosage Forms:


  • Tablet

  • Capsule

  • Tablet for Suspension

  • Powder for Suspension

Therapeutic Class: Antibiotic


Pharmacologic Class: 1st Generation Cephalosporin


Uses For Bio-Cef


Cephalexin is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections.


This medicine is available only with your doctor's prescription.


Before Using Bio-Cef


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of cephalexin in children.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of cephalexin in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving cephalexin.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Cholestyramine

  • Metformin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Colitis (inflammation in gut), history of or

  • Diarrhea, severe, history of—Use with caution. May make these conditions worse.

  • Kidney disease—Use with caution. Effects may be increased because of slower removal of the medicine from the body.

Proper Use of cephalexin

This section provides information on the proper use of a number of products that contain cephalexin. It may not be specific to Bio-Cef. Please read with care.


Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


Shake the oral liquid well before each use. Measure the medicine with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid.


Keep using this medicine for the full treatment time, even if you feel better after the first few doses. Your infection may not clear up if you stop using the medicine too soon.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage forms (capsules or suspension):
    • For infections:
      • Adults and teenagers—The dose is 1000 to 4000 milligrams (mg) per day, taken in divided doses.

      • Children—Use and dose must be determined by your doctor. Dose is based on body weight and must be determined by your doctor. The dose is usually 25 to 100 milligrams (mg) per kilogram (kg) per day, taken in divided doses.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the capsules in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Store the oral liquid in the refrigerator. Throw away any unused medicine after 14 days.


Precautions While Using Bio-Cef


If your symptoms do not improve within a few days, or if they become worse, check with your doctor.


Cephalexin may cause diarrhea, and in some cases it can be severe. Do not take any medicine or give medicine to your child to treat diarrhea without first checking with your doctor. Diarrhea medicines may make the diarrhea worse or make it last longer. If you have any questions about this or if mild diarrhea continues or gets worse, check with your doctor.


Before you or your child have any medical tests, tell the medical doctor in charge that you are using this medicine. The results of some tests may be affected by this medicine.


Bio-Cef Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Diarrhea

Rare
  • Abdominal or stomach pain

  • blistering, peeling, or loosening of the skin

  • chills

  • clay-colored stools

  • cough

  • dark urine

  • diarrhea

  • dizziness

  • fever

  • general tiredness and weakness

  • headache

  • itching

  • joint or muscle pain

  • light-colored stools

  • loss of appetite

  • nausea and vomiting

  • rash

  • red skin lesions, often with a purple center

  • red, irritated eyes

  • sore throat

  • sores, ulcers, or white spots in the mouth or on the lips

  • unpleasant breath odor

  • unusual tiredness or weakness

  • upper right abdominal or stomach pain

  • vomiting of blood

  • yellow eyes or skin

Incidence not known
  • Abdominal or stomach cramps or tenderness

  • back or leg pains

  • black, tarry stools

  • bleeding gums

  • bloating

  • blood in the urine or stools

  • chest pain

  • coughing up blood

  • diarrhea, watery and severe, which may also be bloody

  • difficulty with breathing or swallowing

  • fast heartbeat

  • general body swelling

  • hives

  • increased menstrual flow or vaginal bleeding

  • increased thirst

  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • loss of appetite

  • nosebleeds

  • pain

  • painful or difficult urination

  • pale skin

  • paralysis

  • pinpoint red spots on the skin

  • prolonged bleeding from cuts

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • red or black, tarry stools

  • red or dark brown urine

  • shortness of breath

  • swollen or painful glands

  • tightness in the chest

  • unusual bleeding or bruising

  • unusual weight loss

  • watery or bloody diarrhea

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Incidence not known
  • Acid or sour stomach

  • anxiety

  • belching

  • burning feeling in the chest or stomach

  • difficulty with moving

  • dry mouth

  • heartburn

  • hives or welts

  • hyperventilation

  • indigestion

  • irregular heartbeats

  • irritability

  • itching of the vagina or genital area

  • muscle pain or stiffness

  • nervousness

  • pain during sexual intercourse

  • pain, swelling, or redness in the joints

  • redness of the skin

  • restlessness

  • seeing, hearing, or feeling things that are not there

  • shaking

  • stomach upset

  • trouble with sleeping

  • white or brownish vaginal discharge

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Bio-Cef side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Bio-Cef resources


  • Bio-Cef Side Effects (in more detail)
  • Bio-Cef Use in Pregnancy & Breastfeeding
  • Drug Images
  • Bio-Cef Drug Interactions
  • Bio-Cef Support Group
  • 0 Reviews for Bio-Cef - Add your own review/rating


Compare Bio-Cef with other medications


  • Acne
  • Bacterial Endocarditis Prevention
  • Bacterial Infection
  • Bladder Infection
  • Bone infection
  • Kidney Infections
  • Otitis Media
  • Pharyngitis
  • Prostatitis
  • Skin Infection
  • Upper Respiratory Tract Infection

Saturday 7 February 2009

Sintenyl




Sintenyl may be available in the countries listed below.


Ingredient matches for Sintenyl



Fentanyl

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Sintenyl in the following countries:


  • Switzerland

International Drug Name Search

Thursday 5 February 2009

Minoxi




Minoxi may be available in the countries listed below.


Ingredient matches for Minoxi



Minoxidil

Minoxidil is reported as an ingredient of Minoxi in the following countries:


  • Georgia

  • Israel

International Drug Name Search

Monday 2 February 2009

Ecuaderm




Ecuaderm may be available in the countries listed below.


Ingredient matches for Ecuaderm



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Ecuaderm in the following countries:


  • Venezuela

International Drug Name Search